Edition:
India

ANI Pharmaceuticals Inc (ANIP.OQ)

ANIP.OQ on NASDAQ Stock Exchange Global Market

57.64USD
2:29am IST
Change (% chg)

$-0.30 (-0.52%)
Prev Close
$57.94
Open
$58.50
Day's High
$59.50
Day's Low
$57.29
Volume
71,510
Avg. Vol
55,197
52-wk High
$74.63
52-wk Low
$42.26

Chart for

About

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company is engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The Company focuses on areas, including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations.... (more)

Overall

Beta: 2.84
Market Cap(Mil.): $624.28
Shares Outstanding(Mil.): 11.64
Dividend: --
Yield (%): --

Financials

BRIEF-Ani Pharmaceuticals Enters Five-Year $125 Mln Senior Secured Credit Facility With Citizens Bank

* ANI PHARMACEUTICALS ENTERS FIVE-YEAR $125 MILLION SENIOR SECURED CREDIT FACILITY WITH CITIZENS BANK

29 Dec 2017

BRIEF-Ani Pharmaceuticals Acquires Four NDAs From AstraZeneca For $46.5 Mln

* ANI PHARMACEUTICALS ACQUIRES FOUR NDAS FROM ASTRAZENECA FOR $46.5 MILLION

29 Dec 2017

BRIEF-ANI Pharmaceuticals Q3 gaap earnings per share $0.40

* ANI Pharmaceuticals reports record third quarter and year-to-date 2017 results and narrows full year guidance

02 Nov 2017

BRIEF-ANI Pharmaceuticals announces launch of Oxycodone Hydrochloride oral solution

* ANI Pharmaceuticals Inc announces approval and launch of Oxycodone Hydrochloride oral solution, 100 mg/5ml

01 Sep 2017

Earnings vs. Estimates